Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Product development programs for neglected tropical diseases: A crucial role for expert meetings.
Hussaarts L, van der Weijde K, Dome P, Kourany-Lefoll E, Reinhard-Rupp J, de Vrueh R; Pediatric Praziquantel Consortium. Hussaarts L, et al. Among authors: kourany lefoll e. PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005183. doi: 10.1371/journal.pntd.0005183. eCollection 2017 Feb. PLoS Negl Trop Dis. 2017. PMID: 28231243 Free PMC article. No abstract available.
Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study.
Mahende MK, Huber E, Kourany-Lefoll E, Ali A, Hayward B, Bezuidenhout D, Bagchus W, Kabanywanyi AM. Mahende MK, et al. Among authors: kourany lefoll e. PLoS Negl Trop Dis. 2021 Jun 9;15(6):e0007370. doi: 10.1371/journal.pntd.0007370. eCollection 2021 Jun. PLoS Negl Trop Dis. 2021. PMID: 34106922 Free PMC article. Clinical Trial.
Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial.
N'Goran EK, Odiere MR, Assandé Aka R, Ouattara M, Aka NAD, Ogutu B, Rawago F, Bagchus WM, Bödding M, Kourany-Lefoll E, Tappert A, Yin X, Bezuidenhout D, Badenhorst H, Huber E, Dälken B, Haj-Ali Saflo O. N'Goran EK, et al. Among authors: kourany lefoll e. Lancet Infect Dis. 2023 Jul;23(7):867-876. doi: 10.1016/S1473-3099(23)00048-8. Epub 2023 Mar 6. Lancet Infect Dis. 2023. PMID: 36893784 Clinical Trial.
Challenges and Lessons From Conducting A Paediatric Clinical Trial in Sub-Saharan Africa: The Case of the Praziquantel Oral Dispersible Tablets Phase II Study in Côte d'Ivoire.
N'Goran E, David Aka NA, Ouattara M, Huber E, Bezuidenhout D, Kourany-Lefoll E; Pediatric Praziquantel Consortium. N'Goran E, et al. Among authors: kourany lefoll e. Adv Parasitol. 2019;103:75-89. doi: 10.1016/bs.apar.2018.09.002. Epub 2018 Oct 22. Adv Parasitol. 2019. PMID: 30878059